Clinical Trials in Georgia

Showing 15241-15260 of 19,050 trials

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

NCT01597596

A study to demonstrate comparable safety, efficacy, and pharmacokinetics (PK) of alglucosidase alfa manufactured at the 160 litre (L) and 4000 L scales in participants who had been diagnosed with infantile-onset Pompe disease. Participants were treated with alglucosidase alfa 160 L scale product in the United States (US) and 4000 L scale product in the regions outside the US.

Pompe Disease (Infantile-Onset)Glycogen Storage Disease Type II (GSD II)Glycogenosis 2+1 more

Genzyme, a Sanofi Company4 participantsStarted Aug 2012

Little Rock, Arkansas, United States • Oakland, California, United States • Gainsville, Florida, United States +14 more locations

TERMINATEDPhase 363 miles

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

NCT01345630

The purpose of this study is to assess whether maraviroc administered once daily is non-inferior to emtricitabine/tenofovir also administered once daily each in combination with darunavir/ritonavir in the treatment of antiretroviral-naive patients as evaluated at Week 48 of treatment.

HIV-1

ViiV Healthcare813 participantsStarted Sep 2011

Birmingham, Alabama, United States • Hobson City, Alabama, United States • Hayward, California, United States +174 more locations

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Find Trials by Condition in Georgia

Properties of Mesenchymal Stem Cells in Lung Transplant

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

Safety and Tolerability of Glatiramer Acetate

Genomic Research in Sarcoidosis

The Study of Soy Isoflavones in Asthma

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Tolerance of Healthy Infants Fed Infant Formulas

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Clinical Trial of a Silver Eluting Dressing System

MARCH Renal Substudy

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants